Developer docs
API playgroundTry for free, no card

Search company profiles

Regenera Activa

Full company profile

uuid003hw3o

Namestring
Regenera Activa
Legal namestring
Regenera Activa Worldwide S.L.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Regenera Activa Worldwide S.L. is a Barcelona-based medical device company specializing in regenerative medicine, with its commercial focus on the treatment of androgenetic alopecia (AGA). Founded in 2014 as part of the Remedi Group, the company sells the patented Rigenera Technology platform — comprising the N4SA motorized machine, Sicurstick transmitter, and single-use Rigeneracons consumables — that mechanically disaggregates a small biopsy of the patient's own tissue (typically from the mastoid area) into an injectable autologous micrograft suspension called the AMT Triad. The Triad combines progenitor cells, Human Smart Exosomes (up to 70 billion per session in the 2025 EVO generation), and extracellular matrix, with no laboratory manipulation or culturing step.

The core product is the AMT procedure: a single 30-minute session that produces visible results within roughly three months and can be repeated or combined with hair transplant surgery. The company also markets the Activa Hair professional product line (Tricho6 Technology) and a cosmeceutical range, and has expanded the Rigenera platform into orthopaedics, wound care (including a NATO-validated emergency kit), vitiligo, and skin rejuvenation applications. The most recent platform release is the fourth-generation EVO device, which raises cell viability above 90% and exosome yield by ~50% relative to the previous generation.

Commercially, Regenera Activa operates a B2B sales-led model, selling capital equipment and recurring single-use procedure kits to dermatologists, trichologists, hair transplant surgeons, and aesthetic physicians through an authorized distributor network in 60+ countries. Training and certification programs (10,000+ physicians certified) and 80+ peer-reviewed scientific publications support clinician adoption. Revenue is generated from hardware sales (N4SA system), per-procedure consumable kits, training/certification services, and the Activa Hair product line, with no publicly disclosed pricing or revenue figures.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regenerative medicine devices, autologous micrografting technology, hair restoration treatments, medical device distribution, dermatology clinical devices
Industry3 codes
1Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
CodeHLAAAGAGPrimaryNo
2Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
CodeHLAHALAEPrimaryNo
3Point-of-Care Regenerative Kits & Devices (Processing/Delivery)
CodeHLAMANAKPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Biological Products, (No Disgnostic Substances)2836
Product category
Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Device Sales
TypeHardware Sales
Description

Regenera Activa sells the Rigenera Technology system consisting of the N4SA machine, Sicurstick transmitter, and Rigeneracons consumables to medical professionals and clinics worldwide through a distributor network. The system is required to perform AMT procedures.

regeneraactiva.com
2AMT Procedure Kits
TypeOne Time License
Description

Single-use disposable kits for autologous micrografting procedures. Each procedure requires the patented Rigeneracons and consumables, generating recurring revenue per treatment session. Medical centers purchase these kits to perform AMT procedures on patients.

regeneraactiva.com
3Training and Certification
TypeProfessional Services
Description

The company provides certification programs for medical professionals to become official Regenera Activa Experts. Training includes online webinars, live sessions, and certification pathways for dermatologists and trichologists.

regeneraactiva.com
4Activa Hair Products
TypeHardware Sales
Description

Tricho6 Technology-based professional hair loss treatment products sold to healthcare professionals for application in their clinics. Can be used as standalone treatment or in combination with AMT procedures.

activahair.regeneraactiva.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Others
Pricing details3 tiers
13rd Generation Rigenera Technology
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Up to 80% cell viability; up to 55 billion Human Smart Exosomes per session; manual start/stop button; plastic lead and transmission system. Retail pricing requires contacting the distributor.

professionals.regeneraactiva.com
2EVO 4th Generation Rigenera Technology
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Over 90% cell viability; up to 70 billion Human Smart Exosomes per session; >50% increase in biological components; intelligent electronic control with LCD touchscreen; Smart Microblade Technology; medical metal alloy lid and metallic transmission system. Retail pricing requires contacting the distributor.

professionals.regeneraactiva.com
3Activa Hair Professional Treatment
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Typically 5 sessions required to complete a treatment; procedure takes less than 30 minutes; painless application. Patient pricing set by individual medical centers.

activahair.regeneraactiva.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Activa Hair
Description

A professional hair loss treatment powered by Tricho6 Technology, designed to reactivate the natural hair cycle of follicles. Targets all major causes of hair loss through 6 mechanisms of action.

activahair.regeneraactiva.com
Core offering1 text field

Regenera Activa develops, manufactures, and distributes the Rigenera Technology platform — a CE-marked and FDA-registered medical device system that mechanically fragments small autologous skin biopsies into calibrated micrografts for use in hair restoration and regenerative dermatology procedures. The company sells the Rigenera EVO hardware, single-use sterile consumable kits (Rigeneracons, Sicurstick), AMT procedure kits, the AMT Triad suspension solution, and supporting cosmeceutical and exosome-based products to licensed physicians and clinics worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 450,000+ successful procedures performed worldwide
+5 more records
Product overview1 text field

Regenera Activa is a biotech company specializing in hair follicle regeneration through regenerative medicine. The core offering consists of the patented Rigenera Technology platform and AMT (Autologous Micrografting Technology) procedures. The Rigenera Technology comprises the N4SA machine, Sicurstick transmitter, and Rigeneracons accessories that mechanically process patient tissue to produce AMT Triad solution. The AMT Triad is an injectable suspension of progenitor cells, Human Smart Exosomes, and extracellular matrix. The company also offers Activa Hair, a separate consumer product powered by Tricho6 Technology for broader hair loss treatment. The latest EVO (4th generation) was launched in 2025 with improved specifications including 90%+ cell viability and 70 billion exosomes per session. Additional offerings include Smart Exosomes as a standalone component, cosmeceutical products, and specialized protocols for orthopedics and hair transplant combination treatments.

Product and service5 records
1Rigenera Technology Platform
CategoryMedical Device Platform
Description

CE-marked and FDA-registered medical device platform that mechanically fragments small autologous skin biopsies into calibrated micrografts for hair restoration and regenerative dermatology. Sold to licensed medical professionals and clinics.

2Rigenera EVO (4th generation device)
CategoryMedical Device Hardware
Description

Fourth-generation evolution of the Rigenera mechanical micrografting device hardware, featuring updated engineering for point-of-care autologous tissue fragmentation. Sold to licensed clinics.

3AMT (Autologous Micrografting Technology) Procedure
CategoryClinical Procedure / Protocol
Description

Standardized clinical procedure protocol using the Rigenera device and single-use kits to deliver autologous micrografting treatments for hair restoration. Performed by certified medical practitioners.

4Rigenera Emergency Kit
CategoryMedical Device Kit
Description

Specialized emergency-use kit configuration of the Rigenera micrografting system for time-sensitive regenerative applications.

5Activa Hair (consumer & professional line)
CategoryCosmeceutical / Hair Care Products
Description

Cosmeceutical and topical hair treatment product line sold under the Activa Hair brand to medical professionals and end users, supporting hair restoration protocols including Human Smart Exosomes-based and Tricho6 Technology formulations.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

Regenera Activa operates as a brand under the Remedi Group umbrella. The company is headquartered in Barcelona and functions as a global biotech brand specializing in hair follicle regeneration through regenerative medicine. As part of the Remedi Group, Regenera Activa benefits from shared corporate resources, group brand positioning, and integrated distribution networks across 60+ countries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Human Brain Wave was founded in Italy in 2012 for the fabrication and distribution of Rigenera® technology. The company collaborates with Regenera Activa for the Italian and Spanish markets initially, and has developed the Rigenera® Emergency Kit for military and civilian emergencies. This long-standing partnership since 2012 has enabled continuous technology development and global expansion of the AMT protocols.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Aderans is a Japanese company that pioneered cell-based hair regeneration therapy (using autologous hair follicle cells) and operates a global hair restoration business. It is one of the longest-standing direct competitors in regenerative hair medicine with parallel technology ambitions to Regenera Activa's AMT.

TypeEmerging player
Description

Stemson Therapeutics is an iPSC-based regenerative medicine company focused on engineering hair follicle cells for hair loss treatment. It is an emerging next-generation competitor to Regenera Activa, pursuing an off-the-shelf cell therapy approach that could disrupt the autologous micrografting category if it reaches commercialization.

TypeDirect peer
Description

RepliCel develops RCH-01, a dermal sheath cup cell-based autologous cell therapy for androgenetic alopecia. It is a direct competitor to Regenera Activa in autologous regenerative hair treatments, targeting the same patient population and physician specialty channels with a cell-isolation rather than mechanical-disaggregation approach.

TypeBroad incumbent
Description

Restoration Robotics markets the ARTAS robotic system for hair transplantation procedures. It serves the same physician customer base (hair transplant surgeons and dermatologists) but focuses on robotic follicular unit extraction rather than regenerative tissue processing, making it a complementary rather than direct competitor.

TypeOthers
Description

Eclipse MedCorp manufactures PRP (platelet-rich plasma) preparation systems widely used by dermatologists and hair restoration clinics. It is an adjacent technology in the regenerative hair loss category, often used as a cheaper alternative or adjunct to Regenera Activa's AMT procedures in the same physician practices.

TypeDirect peer
Description

Histogen is a regenerative medicine company developing HSC (Hair Stimulating Complex), a proprietary cell-conditioned media treatment for androgenetic alopecia. It directly competes with Regenera Activa's AMT in the physician-administered hair regeneration category, targeting the same dermatologist and trichologist customer base with a non-autologous regenerative approach.

TypeEmerging player
Description

Follica is a clinical-stage company developing a device-plus-molecule protocol to induce hair follicle neogenesis. It overlaps with Regenera Activa's hair regeneration mission but uses a different mechanism (de novo follicle induction) and serves the same dermatologist channel.

TypeBroad incumbent
Description

Venus Concept sells NeoGraft, an automated follicular unit extraction (FUE) device for hair transplantation, and other aesthetic medicine devices. It addresses the same hair restoration patient population as Regenera Activa through the same physician channel but with a transplantation-focused rather than regenerative approach.

9Human Brain Wave
TypeOthers
Description

Human Brain Wave is the Italian fabrication and distribution partner for the Rigenera technology, founded in 2012 by the original inventors. It is a technology and channel partner rather than a competitor, but operates in the same regenerative medicine space and represents a critical ecosystem participant for Regenera Activa's product supply.

TypeEmerging player
Description

HairClone is a UK-based company offering hair follicle cell banking and expansion services for future autologous transplantation. It is an emerging direct competitor in the regenerative hair loss space with a cell-based, autologous approach comparable to Regenera Activa's tissue-derived micrografting.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regenera Activa

Medical Devicesregeneraactiva.com

What Regenera Activa does

Regenera Activa Worldwide S.L. is a Barcelona-based medical device company specializing in regenerative medicine, with its commercial focus on the treatment of androgenetic alopecia (AGA). Founded in 2014 as part of the Remedi Group, the company sells the patented Rigenera Technology platform — comprising the N4SA motorized machine, Sicurstick transmitter, and single-use Rigeneracons consumables — that mechanically disaggregates a small biopsy of the patient's own tissue (typically from the mastoid area) into an injectable autologous micrograft suspension called the AMT Triad. The Triad combines progenitor cells, Human Smart Exosomes (up to 70 billion per session in the 2025 EVO generation), and extracellular matrix, with no laboratory manipulation or culturing step.

The core product is the AMT procedure: a single 30-minute session that produces visible results within roughly three months and can be repeated or combined with hair transplant surgery. The company also markets the Activa Hair professional product line (Tricho6 Technology) and a cosmeceutical range, and has expanded the Rigenera platform into orthopaedics, wound care (including a NATO-validated emergency kit), vitiligo, and skin rejuvenation applications. The most recent platform release is the fourth-generation EVO device, which raises cell viability above 90% and exosome yield by ~50% relative to the previous generation.

Commercially, Regenera Activa operates a B2B sales-led model, selling capital equipment and recurring single-use procedure kits to dermatologists, trichologists, hair transplant surgeons, and aesthetic physicians through an authorized distributor network in 60+ countries. Training and certification programs (10,000+ physicians certified) and 80+ peer-reviewed scientific publications support clinician adoption. Revenue is generated from hardware sales (N4SA system), per-procedure consumable kits, training/certification services, and the Activa Hair product line, with no publicly disclosed pricing or revenue figures.

Regenera Activa firmographics

Firmographics
Name
Regenera Activa
Legal name
Regenera Activa Worldwide S.L.
Website
https://regeneraactiva.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Regenera Activa is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Regenera Activa business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales: Regenera Activa sells the Rigenera Technology system consisting of the N4SA machine, Sicurstick transmitter, and Rigeneracons consumables to medical professionals and clinics worldwide through a distributor network. The system is required to perform AMT procedures.
  2. AMT Procedure Kits: Single-use disposable kits for autologous micrografting procedures. Each procedure requires the patented Rigeneracons and consumables, generating recurring revenue per treatment session. Medical centers purchase these kits to perform AMT procedures on patients.
  3. Training and Certification: The company provides certification programs for medical professionals to become official Regenera Activa Experts. Training includes online webinars, live sessions, and certification pathways for dermatologists and trichologists.
  4. Activa Hair Products: Tricho6 Technology-based professional hair loss treatment products sold to healthcare professionals for application in their clinics. Can be used as standalone treatment or in combination with AMT procedures.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contract3rd Generation Rigenera Technology
Unit PricingMulti-year contractEVO 4th Generation Rigenera Technology
Unit PricingMulti-year contractActiva Hair Professional Treatment

Go-to-market motion1 record

Distribution channels4 records

Marketing channels10 records

Regenera Activa product offering

Product offering

Core offering

Regenera Activa develops, manufactures, and distributes the Rigenera Technology platform — a CE-marked and FDA-registered medical device system that mechanically fragments small autologous skin biopsies into calibrated micrografts for use in hair restoration and regenerative dermatology procedures. The company sells the Rigenera EVO hardware, single-use sterile consumable kits (Rigeneracons, Sicurstick), AMT procedure kits, the AMT Triad suspension solution, and supporting cosmeceutical and exosome-based products to licensed physicians and clinics worldwide.

Product overview

Regenera Activa is a biotech company specializing in hair follicle regeneration through regenerative medicine. The core offering consists of the patented Rigenera Technology platform and AMT (Autologous Micrografting Technology) procedures. The Rigenera Technology comprises the N4SA machine, Sicurstick transmitter, and Rigeneracons accessories that mechanically process patient tissue to produce AMT Triad solution. The AMT Triad is an injectable suspension of progenitor cells, Human Smart Exosomes, and extracellular matrix. The company also offers Activa Hair, a separate consumer product powered by Tricho6 Technology for broader hair loss treatment. The latest EVO (4th generation) was launched in 2025 with improved specifications including 90%+ cell viability and 70 billion exosomes per session. Additional offerings include Smart Exosomes as a standalone component, cosmeceutical products, and specialized protocols for orthopedics and hair transplant combination treatments.

Differentiator

Problem solved

Functional benefit

Brands

  • Activa Hair: A professional hair loss treatment powered by Tricho6 Technology, designed to reactivate the natural hair cycle of follicles. Targets all major causes of hair loss through 6 mechanisms of action.

Products and services

  • Rigenera Technology Platform CE-marked and FDA-registered medical device platform that mechanically fragments small autologous skin biopsies into calibrated micrografts for hair restoration and regenerative dermatology. Sold to licensed medical professionals and clinics.
  • Rigenera EVO (4th generation device) Fourth-generation evolution of the Rigenera mechanical micrografting device hardware, featuring updated engineering for point-of-care autologous tissue fragmentation. Sold to licensed clinics.
  • AMT (Autologous Micrografting Technology) Procedure Standardized clinical procedure protocol using the Rigenera device and single-use kits to deliver autologous micrografting treatments for hair restoration. Performed by certified medical practitioners.
  • Rigenera Emergency Kit Specialized emergency-use kit configuration of the Rigenera micrografting system for time-sensitive regenerative applications.
  • Activa Hair (consumer & professional line) Cosmeceutical and topical hair treatment product line sold under the Activa Hair brand to medical professionals and end users, supporting hair restoration protocols including Human Smart Exosomes-based and Tricho6 Technology formulations.

Quantifiable outcome

  • 450,000+ successful procedures performed worldwide
  • +5 more outcomes

Companies that use Regenera Activa

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Regenera Activa technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Regenera Activa partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Remedi GroupcoreOthersRegenera Activa operates as a brand under the Remedi Group umbrella. The company is headquartered in Barcelona and functions as a global biotech brand specializing in hair follicle regeneration through regenerative medicine. As part of the Remedi Group, Regenera Activa benefits from shared corporate resources, group brand positioning, and integrated distribution networks across 60+ countries.
  • Human Brain Wave (Italy)coreStrategic or Co-development PartnerHuman Brain Wave was founded in Italy in 2012 for the fabrication and distribution of Rigenera® technology. The company collaborates with Regenera Activa for the Italian and Spanish markets initially, and has developed the Rigenera® Emergency Kit for military and civilian emergencies. This long-standing partnership since 2012 has enabled continuous technology development and global expansion of the AMT protocols.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Regenera Activa competitors and assessment

Company assessment

Direct peers

  • Aderans Company: Aderans is a Japanese company that pioneered cell-based hair regeneration therapy (using autologous hair follicle cells) and operates a global hair restoration business. It is one of the longest-standing direct competitors in regenerative hair medicine with parallel technology ambitions to Regenera Activa's AMT.
  • RepliCel Life Sciences: RepliCel develops RCH-01, a dermal sheath cup cell-based autologous cell therapy for androgenetic alopecia. It is a direct competitor to Regenera Activa in autologous regenerative hair treatments, targeting the same patient population and physician specialty channels with a cell-isolation rather than mechanical-disaggregation approach.
  • Histogen Inc: Histogen is a regenerative medicine company developing HSC (Hair Stimulating Complex), a proprietary cell-conditioned media treatment for androgenetic alopecia. It directly competes with Regenera Activa's AMT in the physician-administered hair regeneration category, targeting the same dermatologist and trichologist customer base with a non-autologous regenerative approach.

Emerging players

  • Stemson Therapeutics: Stemson Therapeutics is an iPSC-based regenerative medicine company focused on engineering hair follicle cells for hair loss treatment. It is an emerging next-generation competitor to Regenera Activa, pursuing an off-the-shelf cell therapy approach that could disrupt the autologous micrografting category if it reaches commercialization.
  • Follica Inc: Follica is a clinical-stage company developing a device-plus-molecule protocol to induce hair follicle neogenesis. It overlaps with Regenera Activa's hair regeneration mission but uses a different mechanism (de novo follicle induction) and serves the same dermatologist channel.
  • HairClone: HairClone is a UK-based company offering hair follicle cell banking and expansion services for future autologous transplantation. It is an emerging direct competitor in the regenerative hair loss space with a cell-based, autologous approach comparable to Regenera Activa's tissue-derived micrografting.

Broad incumbents

  • Restoration Robotics (ARTAS): Restoration Robotics markets the ARTAS robotic system for hair transplantation procedures. It serves the same physician customer base (hair transplant surgeons and dermatologists) but focuses on robotic follicular unit extraction rather than regenerative tissue processing, making it a complementary rather than direct competitor.
  • Venus Concept (NeoGraft): Venus Concept sells NeoGraft, an automated follicular unit extraction (FUE) device for hair transplantation, and other aesthetic medicine devices. It addresses the same hair restoration patient population as Regenera Activa through the same physician channel but with a transplantation-focused rather than regenerative approach.

Others

  • Eclipse MedCorp: Eclipse MedCorp manufactures PRP (platelet-rich plasma) preparation systems widely used by dermatologists and hair restoration clinics. It is an adjacent technology in the regenerative hair loss category, often used as a cheaper alternative or adjunct to Regenera Activa's AMT procedures in the same physician practices.
  • Human Brain Wave: Human Brain Wave is the Italian fabrication and distribution partner for the Rigenera technology, founded in 2012 by the original inventors. It is a technology and channel partner rather than a competitor, but operates in the same regenerative medicine space and represents a critical ecosystem participant for Regenera Activa's product supply.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

Regenera Activa social profiles

Digital presence

Regenera Activa compliance and trust

Trust signal

Compliance9 records

Regenera Activa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regenera Activa leadership team

Management profile

Number of profiles

Regenera Activa funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regenera Activa M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regenera Activa

What does Regenera Activa do?

Regenera Activa develops, manufactures, and distributes the Rigenera Technology platform — a CE-marked and FDA-registered medical device system that mechanically fragments small autologous skin biopsies into calibrated micrografts for use in hair restoration and regenerative dermatology procedures. The company sells the Rigenera EVO hardware, single-use sterile consumable kits (Rigeneracons, Sicurstick), AMT procedure kits, the AMT Triad suspension solution, and supporting cosmeceutical and exosome-based products to licensed physicians and clinics worldwide.

Is Regenera Activa a public or private company?

Regenera Activa is a private company. It is classified as corporate owned and is currently operating.

When was Regenera Activa founded?

Regenera Activa was founded in 2014. It employs 11 to 50 people.

Where is Regenera Activa based?

Regenera Activa is headquartered in Barcelona, Spain, in the Europe region.

How does Regenera Activa make money?

Four revenue lines are on record. Medical Device Sales are the primary driver. The others are AMT Procedure Kits, training and Certification and activa Hair Products.

Who are Regenera Activa's main competitors?

Direct peers on record are Aderans Company, RepliCel Life Sciences and Histogen Inc. Emerging players are Stemson Therapeutics, Follica Inc and HairClone. Broad incumbents are Restoration Robotics (ARTAS) and Venus Concept (NeoGraft). Others are Eclipse MedCorp and Human Brain Wave.

Does Regenera Activa have an API?

No public API is recorded for Regenera Activa.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales